- ICH GCP
- EU臨床試験登録
最新の試験
EudraCT Number: 2020-005019-29 | Sponsor Protocol Number: Rux-cALL-Pol_2020 | Start Date: | ||||||||||||||||
Sponsor Name: Medical University of Lodz | ||||||||||||||||||
Full Title: Single-arm interventional study with ruxolitinib and AIOEP-BFM2017 chemotherapy in children with acute lymphoblastic leukemia and confirmed activation of JAK/STAT pathway. | ||||||||||||||||||
Medical condition: Acute Lymphoblastic Leukemia with confirmed activating of JAK/STAT pathway in children and adolescents | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: PL (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-000730-40 | Sponsor Protocol Number: SOCRATES | Start Date: | |||||||||||
Sponsor Name: Heinrich-Heine-Universität Düsseldorf | |||||||||||||
Full Title: Phase II study evaluating transarterial chemoembolization (TACE) in combination with sorafenib for the treatment of advanced hepatocellular carcinoma (HCC) | |||||||||||||
Medical condition: histologically proven advanced hepatocellular carcinoma (HCC) not suitable for resection or liver transplantation but without extrahepatic manifestations and without previous treatment for HCC | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2009-011148-21 | Sponsor Protocol Number: D0520C00012 | Start Date: | |||||||||||
Sponsor Name: AstraZeneca AB | |||||||||||||
Full Title: A 12-week, randomised, double-blind, placebo-controlled, parallel group, multinational, phase IIb dose range finding study to evaluate the efficacy and safety of AZD9668 administered orally at 3 do... | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) SK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-001316-31 | Sponsor Protocol Number: E01/04/SLIT1-M | Start Date: | ||||||
Sponsor Name: ALK-ABELLO, S.A. | ||||||||
Full Title: TOLERABILIDAD DE LAS VACUNAS ALERGÉNICAS VALORADAS EN UNIDADES DE MASA Y ADMINISTRADAS POR VÍA SUBLINGUAL. ESTUDIO RANDOMIZADO DOBLE CIEGO CONTROLADO CON PLACEBO EN PACIENTES CON ENFERMEDAD ALÉRGIC... | ||||||||
Medical condition: Rinitis o rinoconjuntivitis alérgica perenne (ácaros) o estacional (gramíneas) con/sin síntomas de asma | ||||||||
|
||||||||
Population Age: Children, Adolescents, Under 18, Adults | Gender: Male, Female | |||||||
Trial protocol: ES (Ongoing) | ||||||||
Trial results: View results |
EudraCT Number: 2009-011911-19 | Sponsor Protocol Number: QUE/09 | Start Date: | |||||||||||
Sponsor Name: Ludwig-Maximilian-University of Munich, Department of Psychiatry | |||||||||||||
Full Title: Impact of quetiapine prolong and escitalopram on the hypothalamic-pituitary-adrenocortical (HPA)-axis activity in depressed patients | |||||||||||||
Medical condition: In this study, patients suffering from unipolar depression are investigated. 40 unipolar depressed inpatients (age 18-65) enter the study after the procedure has been fully explained and written in... | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000761-16 | Sponsor Protocol Number: ALXN1210-TMA-314 | Start Date: | |||||||||||
Sponsor Name: Alexion Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 3, Open-label, Single Arm, Multicenter Study of Ravulizumab in Addition to Best Supportive Care in Pediatric Participants (from 1 month to | |||||||||||||
Medical condition: hematopoietic stem cell transplant-associated thrombotic microangiopathy | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) FR (Ongoing) DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-004194-51 | Sponsor Protocol Number: 020520 | Start Date: | ||||||
Sponsor Name: Medical University of Lodz | ||||||||
Full Title: A prospective, randomized, phase III open-label clinical trial with blinded end-point assessment to evaluate the efficacy and safety of cyclosporine and methotrexate in children and adolescent subj... | ||||||||
Medical condition: Atopic dermatitis | ||||||||
|
||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | |||||||
Trial protocol: PL (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005092-13 | Sponsor Protocol Number: MO42623 | Start Date: | |||||||||||
Sponsor Name: F. Hoffmann-La Roche Ltd | |||||||||||||
Full Title: A MULTICENTER, OPEN-LABEL PHASE IV STUDY TO EVALUATE OVERALL HEALTH, PHYSICAL ACTIVITY, AND JOINT OUTCOMES, IN PARTICIPANTS AGED ≥ 13 AND | |||||||||||||
Medical condition: Severe or Moderate Hemophilia A | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Prematurely Ended) DE (Ongoing) ES (Ongoing) IT (Ongoing) HU (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-021802-39 | Sponsor Protocol Number: DB2113374 | Start Date: | |||||||||||
Sponsor Name: GlaxoSmithKline Research & Development Ltd | |||||||||||||
Full Title: A multicenter trial comparing the efficacy and safety of GSK573719/GW642444 with GSK573719 with tiotropium over 24 weeks in subjects with COPD | |||||||||||||
Medical condition: Chronic Obstructive Pulmonary Disease (COPD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001931-27 | Sponsor Protocol Number: STARS-trial | Start Date: | |||||||||||
Sponsor Name: IRCCS Istituto Giannina Gaslini | |||||||||||||
Full Title: Comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS | |||||||||||||
Medical condition: Juvenile idiopathic arthritis (JIA) is an umbrella term that encompasses a heterogeneous group of disorders characterised by prolonged synovial inflammation that may cause destructive damage to joi... | |||||||||||||
|
|||||||||||||
Population Age: Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |